Related references
Note: Only part of the references are listed.Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Dominik Sturm et al.
NATURE REVIEWS CANCER (2014)
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Surasak Phuphanich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Einar Osland Vik-Mo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside
Cheryl Lai-Lai Chiang et al.
CLINICAL CANCER RESEARCH (2013)
Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma
Katharina Ochs et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
Yasuto Akiyama et al.
BMC CANCER (2012)
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
Hilko Ardon et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Clinical Application of a Dendritic Cell Vaccine Raised Against Heat-Shocked Glioblastoma
X. Jie et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical Trial
Der-Yang Cho et al.
WORLD NEUROSURGERY (2012)
Immunotherapeutic Approaches to Hepatocellular Carcinoma Treatment
Alexander G. Miamen et al.
LIVER CANCER (2012)
Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
Robert M. Prins et al.
CLINICAL CANCER RESEARCH (2011)
A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
Chen-Nen Chang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
Camilo E. Fadul et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
John H. Sampson et al.
NEURO-ONCOLOGY (2011)
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
Stuart A. Grossman et al.
CLINICAL CANCER RESEARCH (2010)
Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
John K. Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
Hilko Ardon et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety
Marianela Candolfi et al.
CURRENT GENE THERAPY (2009)
DCVax®-Brain and DC vaccines in the treatment of GBM
Christopher J. Wheeler et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
Christopher J. Wheeler et al.
CANCER RESEARCH (2008)
A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro
Q. Zhou et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
Steven De Vleeschouwer et al.
CLINICAL CANCER RESEARCH (2008)
Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy
David G. Walker et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study
Amy B. Heimberger et al.
NEURO-ONCOLOGY (2008)
Dendritic cell immunotherapy for breast cancer
Alberto Pinzon-Charry et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
LM Liau et al.
CLINICAL CANCER RESEARCH (2005)
Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines
J Kjaergaard et al.
JOURNAL OF NEUROSURGERY (2005)
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial
R Yamanaka et al.
CLINICAL CANCER RESEARCH (2005)
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas
H Ohgaki et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu et al.
CANCER RESEARCH (2004)
Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12
T Kikuchi et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
R Yamanaka et al.
BRITISH JOURNAL OF CANCER (2003)
Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
T Kikuchi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
A fresh look at tumor immunosurveillance and immunotherapy
MJ Smyth et al.
NATURE IMMUNOLOGY (2001)
The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells
PR Walker et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
